Cigarette smoking in patients with schizophrenia in China: Prospective, multicentre study

Australian and New Zealand Journal of Psychiatry

Volumn 44, Issue 5, 2010, Pages 456-462

  Wang, Chuan Yue ^a   Xiang, Yu Tao ^a,b   Weng, Yong Zhen ^a   Bo, Qi Jing ^a   Chiu, Helen F K ^c   Chan, Sandra S M ^c   Lee, Edwin H M ^c   Ungvari, Gabor S ^c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b SHATIN HOSPITAL   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

China; Gender; Schizophrenia; Smoking

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CHINA; CIGARETTE SMOKING; CLINICAL FEATURE; DEMOGRAPHY; DISEASE DURATION; EXCITEMENT; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSTILITY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PATIENT; PROSPECTIVE STUDY; SCHIZOPHRENIA; SENESCENCE; SEX RATIO; UNEMPLOYMENT; UNIVARIATE ANALYSIS; AGE; CLINICAL TRIAL; DRINKING BEHAVIOR; EPIDEMIOLOGY; HOSPITAL MANAGEMENT; MIDDLE AGED; MULTICENTER STUDY; PSYCHOLOGIC TEST; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESTLESSNESS; RISK FACTOR; SEX DIFFERENCE; SMOKING; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; TIME;

ADULT; AGE FACTORS; ALCOHOL DRINKING; CHINA; FEMALE; FOLLOW-UP STUDIES; HOSPITAL ADMINISTRATION; HOSTILITY; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENTS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR AGITATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX FACTORS; SMOKING; SOCIOECONOMIC FACTORS; TIME FACTORS; UNEMPLOYMENT;

EID: 77951274916     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.3109/00048670903493348     Document Type: Article

References (52)

1. Fagerstrom K, Aubin HJ. Management of smoking cessation in patients with psychiatric disorders. Curr Med Res Opin 2009; 25:511-518.
2. Kalman D, Morissette SB, George TP. Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 2005; 14:106-123. (Pubitemid 40577885)
3. McCreadie RG. Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study. Br J Psychiatry 2002; 181: 321-325. (Pubitemid 35178564)
4. Williams JM, Ziedonis D. Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav 2004; 29:1067-1083. (Pubitemid 38962332)
5. Yang GH, Ma JM, Liu N, Zhou LN. Smoking and passive smoking in Chinese, 2002. Chin J Epidemiol 2005; 26:77-83 (in Chinese).
6. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, Bor DH. Smoking and mental illness: a populationbased prevalence study. JAMA 2000; 284:2606-2610.
7. de Leon J. Smoking and vulnerability for schizophrenia. Schizophr Bull 1996; 22:405-409. (Pubitemid 26295343)
8. Esterberg ML, Jones EM, Compton MT, Walker EF. Nicotine consumption and schizotypy in fi rst-degree relatives of individuals with schizophrenia and non-psychiatric controls. Schizophr Res 2007; 97:6-13.
9. George TP, Krystal JH. Comorbidity of psychiatric and substance abuse disorders. Curr Opin Psychiatry 2000; 13:327-331.
10. Hughes JR, Gust SW, Skoog K, Keenan RM, Fenwick JW. Symptoms of tobacco withdrawal. A replication and extension. Arch Gen Psychiatry 1991; 48:52-59.
11. Hennekens CH, Hennekens AR, Hollar D, Casey DE. Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005; 150:1115-1121. (Pubitemid 41773510)
12. Culhane MA, Schoenfeld DA, Barr RS et al. Predictors of early abstinence in smokers with schizophrenia. J Clin Psychiatry 2008; 69:1743-1750.
13. Hannerz H, Borga P, Borritz M. Life expectancies for individuals with psychiatric diagnoses. Public Health 2001; 115:328-337. (Pubitemid 32898841)
14. Botts S, Littrell R, de Leon J. Variables associated with high olanzapine dosing in a state hospital. J Clin Psychiatry 2004; 65: 1138-1143.
15. de Leon J, Dadvand M, Canuso C, White AO, Stanilla JK, Simpson GM. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am J Psychiatry 1995; 152:453-455.
16. Goff DC, Henderson DC, Amico E. Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects. Am J Psychiatry 1992; 149:1189-1194.
17. Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 1986; 143:993-997.
18. McEvoy JP, Freudenreich O, Wilson WH. Smoking and therapeutic response to clozapine in patients with schizophrenia. Biol Psychiatry 1999; 46:125-129. (Pubitemid 29296825)
19. Xiu X, Puskar NL, Shanata JA, Lester HA, Dougherty DA. Nicotine binding to brain receptors requires a strong cation-pi interaction. Nature 2009; 458:534-537.
20. Ziedonis DM, Kosten TR, Glazer WM, Frances RJ. Nicotine dependence and schizophrenia. Hosp Community Psychiatry 1994; 45:204-206.
21. de Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 2005; 76:135-157. (Pubitemid 40812332)
22. George TP, Ziedonis DM, Feingold A et al. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry 2000; 157:1835-1842.
23. Chen DC, Zhang XY, Li YL et al. Association of smoking and psychiatric symptoms, clinical characteristics and cognitive function in fi rst-episode schizophrenia inpatients. Chin Ment Health J 2009; 23:1-4 (in Chinese).
24. Kelly DL, McMahon RP, Weiner E et al. Lack of benefi cial galantamine effect for smoking behavior: a double-blind randomized trial in people with schizophrenia. Schizophr Res 2008; 103: 161-168.
25. Tang YL, George TP, Mao PX, Cai ZJ, Chen Q. Cigarette smoking in Chinese male inpatients with schizophrenia: a cross-sectional analysis. J Psychiatr Res 2007; 41:43-48. (Pubitemid 44708205)
26. Sun SY, Zou YZ. Smoking and quality of life in schizophrenia patients. Modern Rehabil 2000; 4:1435 (in Chinese).
27. Weng YZ, Xu MJ, Li DL, Guo FY, Huang Q, Fu T. Assessment of expressed emotion in family members of schizophrenic patients in Beijing. Modern Rehabil 2001; 5:39-42.
28. Ma X, Xiang YT, Cai ZJ et al. Smoking and psychiatric disorders in the rural and urban regions of Beijing, China: a communitybased survey. Drug Alcohol Depend 2009; 100:146-152.
29. Wang YH, Heng KL, Luo M et al. A study of alcohol dependence and related factors for various professions in Panzhihua city. Chin J Behav Med Sci 1999; 8:105-108 (in Chinese).
30. Xiang YT, Ma X, Lu JY et al. Alcohol-related disorders in Beijing, China: prevalence, sociodemographic correlates, and unmet need for treatment. Alcohol Clin Exp Res 2009; 33: 1111-1118.
31. Overall JE, Beller SA. The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research: I. Factor structure on an inpatient unit. J Gerontol 1984; 39:187-193. (Pubitemid 14156164)
32. He YL, Zhang MY. The positive and negative syndrome scale (PANSS) and its application. J Clin Psychiatry 1997; 7:353-355 (in Chinese).
33. Marder SR, Davis JM, Chouinard G. The effects of risperidone on the fi ve dimensions of schizophrenia derived by factor analysis: combined results of the North American trials. J Clin Psychiatry 1997; 58:538-546. (Pubitemid 28100274)
34. National Institute of Mental Health. TESS (Treatment Emergent Symptom Scale-Write-in). Psychopharmacol Bull 1985; 21: 1069-1072.
35. Chinese Center for Disease Control and Prevention. The survey on smoking in Chinese population in 1996. Beijing: China Association For Science and Technology; 1997 (in Chinese).
36. Wen XZ, Chen WQ, Lu CY et al. Determinants of attempt and success in smoking cessation among male secondary school students. J Hyg Res 2006; 35:317-319 (in Chinese).
37. Li J, Zhang TL, Wang B, Li XW. An effi cacy analysis of bupropion for smoking cessation in schizophrenia. Chin J New Drugs Clin Remedies 2009; 28:231-234 (in Chinese).
38. Yang GH. Epidemiologic survey on smoking in China, 1996. Bull Chin Cancer 1998; 7:3-5 (in Chinese).
39. Chong SA, Choo HL. Smoking among Chinese patients with schizophrenia. Aust N Z J Psychiatry 1996; 30:350-353.
40. Conway JL. Exogenous nicotine normalises sensory gating in schizophrenia; therapeutic implications. Med Hypotheses 2009; 73:259-262.
41. Dervaux A, Laqueille X. Smoking and schizophrenia: epidemiological and clinical features. Encephale 2008; 34:299-305.
42. George TP, Vessicchio JC, Termine A et al. Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology 2002; 26:75-85. (Pubitemid 34075278)
43. Desai HD, Seabolt J, Jann MW. Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs 2001; 15:469-494. (Pubitemid 32601905)
44. Aguilar MC, Gurpegui M, Diaz FJ, de Leon J. Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions. Br J Psychiatry 2005; 186:215-221. (Pubitemid 40343815)
45. Overall J, Gorham D. The brief psychiatric rating scale. Psychol Rep 1962; 10:799-812.
46. Kotov R, Guey LT, Bromet EJ, Schwartz JE. Smoking in schizophrenia: diagnostic specifi city, symptom correlates, and illness severity. Schizophr Bull 2010; 36:173-181.
47. Liao DL, Yang JY, Lee SM, Chen H, Tsai SJ. Smoking in chronic schizophrenic inpatients in Taiwan. Neuropsychobiology 2002; 45:172-175. (Pubitemid 34827802)
48. Martin CR, Allan R, Fleming M, Atkinson J. Mood and smoking in schizophrenia. J Psychiatr Ment Health Nurs 2008; 15:722-727.
49. Campo-Arias A, Diaz-Martinez LA, Rueda-Jaimes GE et al. Smoking is associated with schizophrenia, but not with mood disorders, within a population with low smoking rates: a matched case-control study in Bucaramanga, Colombia. Schizophr Res 2006; 83:269-276.
50. de Leon J, Susce MT, Diaz FJ, Rendon DM, Velasquez DM. Variables associated with alcohol, drug, and daily smoking cessation in patients with severe mental illnesses. J Clin Psychiatry 2005; 66:1447-1455. (Pubitemid 41779544)
51. Hertling I, Ramskogler K, Dvorak A et al. Craving and other characteristics of the comorbidity of alcohol and nicotine dependence. Eur Psychiatry 2005; 20:442-450. (Pubitemid 41318012)
52. Chen HH, Fan CL, Du J, Sun HM, Zhao M. DSM-IV axis I diagnoses analysis in 506 patients with substance dependence. Chin J Drug Depend 2009; 18:200-202 (in Chinese).